| Excess risk of chronic physical conditions associated with depression and anxiety R Bhattacharya, C Shen, U Sambamoorthi BMC psychiatry 14, 1-10, 2014 | 170 | 2014 |
| Antidepressant use and new‐onset diabetes: a systematic review and meta‐analysis S Bhattacharjee, R Bhattacharya, GA Kelley, U Sambamoorthi Diabetes/metabolism research and reviews 29 (4), 273-284, 2013 | 88 | 2013 |
| Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia R Bhattacharya, S Chatterjee, RM Carnahan, RR Aparasu The American journal of geriatric pharmacotherapy 9 (6), 434-441, 2011 | 59 | 2011 |
| Type of multimorbidity and complementary and alternative medicine use among adults M Alwhaibi, R Bhattacharya, U Sambamoorthi Evidence‐Based Complementary and Alternative Medicine 2015 (1), 362582, 2015 | 37 | 2015 |
| Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression R Bhattacharya, C Shen, AB Wachholtz, N Dwibedi, U Sambamoorthi BMC psychiatry 16, 1-14, 2016 | 34 | 2016 |
| A real‐world study of the effect of timing of insulin initiation on outcomes in older medicare beneficiaries with type 2 diabetes mellitus R Bhattacharya, S Zhou, W Wei, M Ajmera, U Sambamoorthi Journal of the American Geriatrics Society 63 (5), 893-901, 2015 | 34 | 2015 |
| Health behaviors among breast cancer patients and survivors KM Kelly, R Bhattacharya, S Dickinson, H Hazard Cancer nursing 38 (3), E27-E34, 2015 | 28 | 2015 |
| A real-world observational study of time to treatment intensification among elderly patients with inadequately controlled type 2 diabetes mellitus M Ajmera, A Raval, S Zhou, W Wei, R Bhattacharya, C Pan, ... Journal of managed care & specialty pharmacy 21 (12), 1184, 2015 | 26 | 2015 |
| Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults R Bhattacharya, M Ajmera, S Bhattacharjee, U Sambamoorthi Diabetes research and clinical practice 105 (2), 251-260, 2014 | 26 | 2014 |
| Depression and ambulatory care sensitive hospitalizations among Medicare beneficiaries with chronic physical conditions R Bhattacharya, C Shen, U Sambamoorthi General hospital psychiatry 36 (5), 460-465, 2014 | 20 | 2014 |
| Patient-reported outcomes in KEYNOTE-564: adjuvant pembrolizumab versus placebo for renal cell carcinoma TK Choueiri, P Tomczak, SH Park, B Venugopal, S Symeonides, J Hajek, ... The Oncologist 29 (2), 142-150, 2024 | 17 | 2024 |
| Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics R Bhattacharya, RA Harvey, K Abraham, J Rosen, P Mehta Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20 (3-4), 251-259, 2019 | 16 | 2019 |
| Variations of depression treatment among women with hypertension EV Atkins, U Sambamoorthi, R Bhattacharya Health care for women international 36 (6), 730-750, 2015 | 12 | 2015 |
| Prevalence of anticholinergic use among older home health patients SS McNeely, R Bhattacharya, RR Aparasu Journal of Clinical Nursing 22 (1-2), 285-288, 2013 | 11 | 2013 |
| Disease‐free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: a retrospective analysis of surveillance, epidemiology … NB Haas, Y Song, J Willemann Rogerio, S Zhang, C Carley, JJ Zhu, ... International Journal of Urology 30 (3), 272-279, 2023 | 8 | 2023 |
| Clinical and economic burdens of recurrence following nephrectomy for intermediate high-or high-risk renal cell carcinoma: A retrospective analysis of Surveillance … M Sundaram, Y Song, JW Rogerio, S Zhang, R Bhattacharya, O Adejoro, ... Journal of Managed Care & Specialty Pharmacy 28 (10), 1149-1160, 2022 | 7 | 2022 |
| A comparison of home health utilization, outcomes, and cost between Medicare Advantage and traditional Medicare AW Casebeer, D Ronning, R Schwartz, C Long, R Bhattacharya, C Uribe, ... Medical Care 60 (1), 66-74, 2022 | 6 | 2022 |
| Disease-free survival as a predictor of overall survival in localized renal cell carcinoma (RCC) following first nephrectomy. NB Haas, Y Song, J Willemann Rogerio, S Zhang, O Adejoro, C Carley, ... Journal of Clinical Oncology 39 (15_suppl), 4581-4581, 2021 | 6 | 2021 |
| Cost-effectiveness analysis of pembrolizumab as an adjuvant treatment of renal cell carcinoma post-nephrectomy in the United States Y Lai, AG Bensimon, E Gao, R Bhattacharya, R Xu, J Chevure, K Imai, ... Clinical Genitourinary Cancer 21 (5), 612. e1-612. e11, 2023 | 4 | 2023 |
| Comparing medical utilization and cost outcomes in oral versus injectable immunotherapy users with chronic inflammatory joint and skin diseases R Bhattacharya, K Herren, I Poonawalla, S Bunniran, A Bloomfield, ... Journal of Managed Care & Specialty Pharmacy 26 (10), 1246-1256, 2020 | 4 | 2020 |
